TY - JOUR
T1 - Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease
AU - Bissessor, Naylin
AU - Wee, Yong Shen
AU - Jayasinghe, Rohan
AU - Zeng, Irene
AU - Lowe, Boris
AU - Kolbe, John
AU - Ellyet, Kevin
AU - Kerr, Andrew
AU - White, Harvey
AU - Stewart, Ralph
PY - 2010
Y1 - 2010
N2 - Background: Assessing the effects of valvular heart disease on functional capacity is important for optimal timing of surgery. Aim: To determine whether N-terminal pro-B type natriuretic peptide (NT-proBNP) and lung spirometry predict maximum oxygen consumption (pVO2) on cardio-pulmonary exercise testing in patients with mixed heart valve disease. Methods: Forty-five clinically stable patients with moderate-severe stenosis and/or regurgitation of the aortic, mitral and/or tricuspid valves were studied. The ability of echocardiography, NT-proBNP, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) to predict impaired pVO2 was determined. Results: On univariate analysis the natural logarithm of NT-proBNP explained more of the variation in pVO2 (r2 = 0.40, p < 0.0001) than valve severity score (r2 = 0.20, p = 0.002), pulmonary artery pressure (r2 = 0.21, p = 0.005), left atrial area index (r 2 = 0.25, p = 0.001) or LV ejection fraction (r2 = 0.02, p = 0.4). Low lean body weight (r2 = 0.21, p = 0.002), FEV1 (r 2 = 0.26, p = 0.0003) and FVC (r2 = 0.20, p = 0.002) were also associated with pVO2. In multi-variable analysis independent determinants of pVO2 were NT-proBNP (r2 = 0.27, p = 0.001), FVC (r 2 = 0.20, p = 0.0002) and lean body weight (r2 = 0.23, p = 0.001). NT-proBNP and FVC together were better predictors of pVO2 < 60% (C statistic = 0.83, 95% CI 0.71, 0.95) than either NT-proBNP (C = 0.80, 95% CI 0.66, 0.94) or FVC (C =0.73, 95% CI 0.57, 0.89) alone. NT-proBNP, FVC and age also predicted excessive ventilation on cardio-pulmonary exercise (combined r2 = 0.54, p < 0.0001). Conclusion: In patients with mixed heart valve disease NT-proBNP and spirometry provide a more reliable assessment of functional capacity than assessment by echocardiography and symptoms alone.
AB - Background: Assessing the effects of valvular heart disease on functional capacity is important for optimal timing of surgery. Aim: To determine whether N-terminal pro-B type natriuretic peptide (NT-proBNP) and lung spirometry predict maximum oxygen consumption (pVO2) on cardio-pulmonary exercise testing in patients with mixed heart valve disease. Methods: Forty-five clinically stable patients with moderate-severe stenosis and/or regurgitation of the aortic, mitral and/or tricuspid valves were studied. The ability of echocardiography, NT-proBNP, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) to predict impaired pVO2 was determined. Results: On univariate analysis the natural logarithm of NT-proBNP explained more of the variation in pVO2 (r2 = 0.40, p < 0.0001) than valve severity score (r2 = 0.20, p = 0.002), pulmonary artery pressure (r2 = 0.21, p = 0.005), left atrial area index (r 2 = 0.25, p = 0.001) or LV ejection fraction (r2 = 0.02, p = 0.4). Low lean body weight (r2 = 0.21, p = 0.002), FEV1 (r 2 = 0.26, p = 0.0003) and FVC (r2 = 0.20, p = 0.002) were also associated with pVO2. In multi-variable analysis independent determinants of pVO2 were NT-proBNP (r2 = 0.27, p = 0.001), FVC (r 2 = 0.20, p = 0.0002) and lean body weight (r2 = 0.23, p = 0.001). NT-proBNP and FVC together were better predictors of pVO2 < 60% (C statistic = 0.83, 95% CI 0.71, 0.95) than either NT-proBNP (C = 0.80, 95% CI 0.66, 0.94) or FVC (C =0.73, 95% CI 0.57, 0.89) alone. NT-proBNP, FVC and age also predicted excessive ventilation on cardio-pulmonary exercise (combined r2 = 0.54, p < 0.0001). Conclusion: In patients with mixed heart valve disease NT-proBNP and spirometry provide a more reliable assessment of functional capacity than assessment by echocardiography and symptoms alone.
KW - Aortic valve
KW - BNP
KW - Cardio-pulmonary testing
KW - Mitral valve
KW - Spirometry
UR - http://www.scopus.com/inward/record.url?scp=76749109040&partnerID=8YFLogxK
M3 - Article
C2 - 20131183
AN - SCOPUS:76749109040
VL - 68
SP - 1
EP - 10
JO - Kardiologia Polska
JF - Kardiologia Polska
SN - 0022-9032
IS - 1
ER -